Lonza Potelligent CHOK1SV host cell line

Friday, 20 November, 2009 | Supplied by: Capsugel Australia Pty Ltd


Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.

The cell line retains the features of a high-productivity cell line (robust, high-yielding, scalable) and the bioprocess platform for CHOK1SV is repeatable in the new cell line.

Antibodies produced by the new cell line: exhibit enhanced antibody dependent cellular cytotoxicity (ADCC) even with the low-ADCC allotype of CD16, overcoming CD16 polymorphism; can exert potent cytotoxic effects when their target antigen is low; work in whole blood; and retain required features of antibodies, such as Protein A binding.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Cayman Chemical Mouse Neutrophil Isolation Kit

Cayman's Neutrophil (mouse) Isolation Kit is designed to provide a streamlined method for...

LumiMount Fluorescence Mounting Medium

Lumiprobe's LumiMount is an aqueous-based mounting medium for coverslipping cells and tissues...

Innovative Research Animal Biologicals

Innovative Research offers a comprehensive selection of biological products sourced from various...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd